High prevalence of the anti-nucleosome antibodies (anti-NCS) in patients with systemic lupus erythematosus (SLE) of recent-onset.

被引:0
|
作者
Simón, JA [1 ]
Cabiedes, J [1 ]
Sánchez-Guerrero, J [1 ]
Ortiz, E [1 ]
Varela, JA [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico
来源
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S296 / S296
页数:1
相关论文
共 50 条
  • [21] The prevalence anti-nucleosome antibodies detected by enzyme-linked immunosorbent assays (ELISA) in systemic lupus patients
    Putova, I
    Dostal, C
    Becvar, R
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 206 - 206
  • [22] Association of anti-nucleosome antibodies with disease flare in serological active clinical quiescent systemic lupus erythematosus patients.
    Ng, KP
    Manson, JJ
    Isenberg, DA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S181 - S181
  • [23] Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus
    Li, Timothy
    Prokopec, Stephenie D.
    Morrison, Stacey
    Lou, Wendy
    Reich, Heather
    Gladman, Dafna
    Urowitz, Murray
    Scholey, James
    Fortin, Paul R.
    Boutros, Paul C.
    Wither, Joan
    Landolt-Marticorena, Carolina
    RHEUMATOLOGY, 2015, 54 (03) : 449 - 457
  • [24] Anti-nucleosome antibodies increase the risk of renal relapse in a prospective cohort of patients with clinically inactive systemic lupus erythematosus
    Norma Alejandra Rodriguez-Jimenez
    Edsaul Emilio Perez-Guerrero
    Jorge Ivan Gamez-Nava
    Dalia Isabel Sanchez-Mosco
    Ana Miriam Saldaña-Cruz
    Miriam Fabiola Alcaraz-Lopez
    Nicte Selene Fajardo-Robledo
    Jose Francisco Muñoz-Valle
    David Bonilla-Lara
    Valeria Diaz-Rizo
    Laura Gonzalez-Lopez
    Scientific Reports, 10
  • [25] Anti-nucleosome, anti-dsDNA and anti-histone autoantibodies reactivity in systemic lupus erythematosus.
    Herráez, O
    Garcia-Berrocal, B
    González, C
    Navajo, A
    González-Buitrago, JM
    CLINICAL CHEMISTRY, 2002, 48 (06) : A147 - A147
  • [26] Anti-nucleosome antibodies increase the risk of renal relapse in a prospective cohort of patients with clinically inactive systemic lupus erythematosus
    Alejandra Rodriguez-Jimenez, Norma
    Emilio Perez-Guerrero, Edsaul
    Ivan Gamez-Nava, Jorge
    Isabel Sanchez-Mosco, Dalia
    Miriam Saldana-Cruz, Ana
    Fabiola Alcaraz-Lopez, Miriam
    Selene Fajardo-Robledo, Nicte
    Francisco Munoz-Valle, Jose
    Bonilla-Lara, David
    Diaz-Rizo, Valeria
    Gonzalez-Lopez, Laura
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [27] Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis
    Bizzaro, Nicola
    Villalta, Danilo
    Giavarina, Davide
    Tozzoli, Renato
    AUTOIMMUNITY REVIEWS, 2012, 12 (02) : 97 - 106
  • [28] Isolation of anti-nucleosome antibodies from the plasma of lupus nephritis patients
    R. Suenaga
    K. Mitamura
    N. I. Abdou
    Clinical Rheumatology, 1998, 17 : 189 - 194
  • [29] Antibodies anti-nucleosome and anti-C1Q-relationship with activity of sytemic lupus erythematosus
    Bautista, A. J.
    Ferro, E.
    Restrepo, J. F.
    Rondon, F.
    Iglesias, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 456 - 456
  • [30] Anti-Nucleosome Antibodies Versus Anti-DNA Antibodies in the Diagnosis and Monitoring of Activity of Systemic Lupus Erytematosus
    Borrell Panos, Helena
    Narvaez, Javier
    Bas, Jordi
    Armengol, Eulalia
    Aparicio, Maria
    Pascual, Maria
    Lopez de Recalde, Merce
    Miquel Nolla, Joan
    ARTHRITIS & RHEUMATOLOGY, 2015, 67